Comparative analysis of pulmonary vein isolation strategies using pulsed field, cryoballoon, and robotic magnetic navigation ablation
Xiao-Yu Liu , Ying Liu , Ling-Ling Qian , Jie Zheng , Ku-Lin Li , Hua-Yan You , Shi-Peng Dang , Xiao-Xi Zhao , Ru-Xing Wang
Vessel Plus ›› 2026, Vol. 10 ›› Issue (1) : 34
Aim: Pulsed field ablation (PFA) has emerged as a promising strategy for catheter ablation of atrial fibrillation (AF). This study compared perioperative outcomes of pulmonary vein isolation (PVI) performed using robotic magnetic navigation (RMN), cryoballoon (CRYO) ablation, and PFA.
Methods: This retrospective study included patients with AF who underwent PVI using RMN ablation (RMN group, n = 112), CRYO ablation (CRYO group, n = 189), or PFA (PFA group, n = 50). Procedural characteristics, perioperative complications, and postoperative recovery were analyzed.
Results: Total procedure time was longer in the PFA group than in the CRYO group but shorter than in the RMN group (123.9 ± 14.0 vs. 98.3 ± 14.3 vs. 147.9 ± 19.3 min, P < 0.001). However, left atrial procedure time was shortest in the PFA group (26.6 ± 6.4 vs. 44.7 ± 12.1 vs. 95.1 ± 20.5 min, P < 0.001). Fluoroscopy time was comparable between the PFA and CRYO groups, and significantly shorter in the RMN group (15.2 ± 3.0 vs. 15.0 ± 3.1 vs. 7.4 ± 2.5 min, P < 0.001). Although acute procedural success was comparable across groups, first-pass PVI was achieved more frequently with PFA than with CRYO or RMN {50/50 [100%] vs. 170/189 [89.9%] vs. 100/112 [89.3%], P = 0.030}. The overall incidence of perioperative complications did not differ significantly among the three groups.
Conclusion: PFA demonstrated acute safety and efficacy comparable to those of RMN and CRYO ablation for AF, while offering shorter left atrial procedure time and a higher rate of first-pass isolation.
Pulsed field ablation / robotic magnetic navigation / cryoballoon / atrial fibrillation
| [1] |
|
| [2] |
Andrade JG, Wells GA, Deyell MW, et al.; EARLY-AF Investigators. Cryoablation or drug therapy for initial treatment of atrial fibrillation.N Engl J Med2021;384:305-15 |
| [3] |
|
| [4] |
|
| [5] |
Reichlin T, Kueffer T, Badertscher P, et al.; SINGLE SHOT CHAMPION Investigators. Pulsed field or cryoballoon ablation for paroxysmal atrial fibrillation.N Engl J Med2025;392:1497-507 |
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
Reddy VY, Gerstenfeld EP, Natale A, et al.; ADVENT Investigators. Pulsed field or conventional thermal ablation for paroxysmal atrial fibrillation.N Engl J Med2023;389:1660-71 |
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
Ekanem E, Reddy VY, Schmidt B, et al.; MANIFEST-PF Cooperative. Multi-national survey on the methods, efficacy, and safety on the post-approval clinical use of pulsed field ablation (MANIFEST-PF).Europace2022;24:1256-66 PMCID:PMC11271404 |
| [27] |
Verma A, Haines DE, Boersma LV, et al.; PULSED AF Investigators. Pulsed field ablation for the treatment of atrial fibrillation: PULSED AF pivotal trial.Circulation2023;147:1422-32 PMCID:PMC10158608 |
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
/
| 〈 |
|
〉 |